Pharmaceutical Solid Dosage Contract Market

The pharmaceuticals solid dosage contract manufacturing comes under the category of the pharmaceutical formulations. It is the largest segment of all the type of the pharmaceutical formulation outsourcing.
Pharmaceutical Solid Dosage Contract Market contains market size and forecasts of Pharmaceutical Solid Dosage Contract Manufacturing in Global, including the following market information:
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pharmaceutical Solid Dosage Contract Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Solid Dosage Contract Manufacturing include Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited, Alkermes, BioPharma Solutions, Cytovance Biologics, DPT Laboratories, Fresenius Kabi and Halo Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceutical Solid Dosage Contract Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Solid Dosage Contract Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsule
Lozenge
Powder
Others
Global Pharmaceutical Solid Dosage Contract Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Segment Percentages, by Application, 2021 (%)
Instant Release
Sustained Release
Extended Release
Effervescent Tablets
Chewable Tablets
Enteric Release
Global Pharmaceutical Solid Dosage Contract Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pharmaceutical Solid Dosage Contract Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Solid Dosage Contract Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pharmaceutical Solid Dosage Contract Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Catalent Pharma Solutions
Jubilant Life Sciences Limited
Alkermes
BioPharma Solutions
Cytovance Biologics
DPT Laboratories
Fresenius Kabi
Halo Pharmaceutical
Lyophilization Technology
Mikart
Pillar5 Pharma
Haupt Pharma
Althea Technologies
Associates of Cape Cod
Covance
Emergent BioSolutions